scholarly journals Vitamin Deficiency Among the Elderly Institutionalized Patients

10.5772/67396 ◽  
2017 ◽  
Author(s):  
Hanadi Khamis Alhamad ◽  
Navas Nadukkandiyil ◽  
Essa Mubarak Al Sulaiti
Keyword(s):  
The Elderly ◽  
Vitamin Deficiency ◽  
Institutionalized Patients

Some Calculations on the Prevalence of Dementia in Canada

1987 ◽  
Vol 32 (2) ◽  
pp. 81-86 ◽  
Author(s):  
E.R. Jeans ◽  
E. Helmes ◽  
H. Merskey ◽  
J. Mcd. Robertson ◽  
K.A. Rand
Keyword(s):  
Elderly Population ◽  
The Elderly ◽  
Epidemiological Studies ◽  
Age Group ◽  
Specific Population ◽  
Observation Scale ◽  
Epidemiology Of Dementia ◽  
Institutionalized Patients ◽  
Prevalence Of Dementia

The epidemiology of dementia in Canada is not known. However, we report figures on the frequency of dementia in institutions in Ontario based upon the use of a multidimensional observation scale for the assessment of the elderly. These findings on institutionalized patients can be extrapolated to the whole elderly population, but the procedure is clearly too conservative by comparison with findings in other countries and in the light of the known occurrence of numbers of demented patients outside institutions. Ratios in different sutidies for the numbers of patients with dementia outside institutions and within institutions range from 1:1 to 6:1. Using a ratio of 2:1 and applying it to age specific population figures, a prevalence of dementia in Canada of 222,324 for those over 65 is obtained with a rate of 9.4% in that age group. When the figures projected in this way are compared with five epidemiological studies for the rate of dementia elsewhere, the Canadian figure which we have obtained ranks fourth out of six. This estimate provides potential figures on which to base the planning of services, provided that the inferential nature of the estimates is fully recognized.

scholarly journals Impact of the Severity of Alzheimer’s Disease on the Quality of Life, Activities of Daily Living, and Caregiving Costs for Institutionalized Patients on Anti-Alzheimer Medications in Japan

2021 ◽  
pp. 1-8
Author(s):  
Takumi Ashizawa ◽  
Ataru Igarashi ◽  
Yukinori Sakata ◽  
Mie Azuma ◽  
Kenichi Fujimoto ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Activities Of Daily Living ◽  
Daily Living ◽  
The Elderly ◽  
The Mean ◽  
Institutionalized Patients ◽  
The Impact

Background: Alzheimer’s disease (AD) increases societal costs and decreases the activities of daily living (ADL) and quality of life (QoL) of the affected individuals. Objective: We assess the impact of AD severity on ADL, QoL, and caregiving costs in Japanese facilities for the elderly. Methods: Patients with AD in facilities for the elderly were included (47 facilities, N = 3,461). The QoL, ADL, and disease severity of patients were assessed using Barthel Index (BI), EuroQoL-5D-5L (EQ-5D-5L), and Mini-Mental State Examination (MMSE), respectively. Annual caregiving costs were estimated using patients’ claims data. The patients were subcategorized into the following three groups according to the MMSE score: mild (21≤MMSE≤30), moderate (11≤MMSE≤20), and severe (0≤MMSE≤10). Changes among the three groups were evaluated using the Jonckheere-Terpstra test. Results: Four hundred and one participants were on anti-AD medicines, of whom 287 (age: 86.1±6.4 years, 76.7% women) in the mild (n = 53, 84.0±6.9 years, 71.7%), moderate (n = 118, 86.6±5.9 years, 76.3%), and severe (n = 116, 86.6±6.5 years, 79.3%) groups completed the study questionnaires. The mean BI and EQ-5D-5L scores for each group were 83.6, 65.1, and 32.8 and 0.801, 0.662, and 0.436, respectively. The mean annual caregiving costs were 2.111, 2.470, and 2.809 million JPY, respectively. As AD worsened, the BI and EQ-5D-5L scores decreased and annual caregiving costs increased significantly. Conclusion: AD severity has an impact on QoL, ADL, and caregiving costs.

scholarly journals Telemedicine and Geriatrics in France: Inventory of Experiments

2018 ◽  
Vol 2018 ◽  
pp. 1-10 ◽  
Author(s):  
A. A. Zulfiqar ◽  
A. Hajjam ◽  
S. Talha ◽  
M. Hajjam ◽  
J. Hajjam ◽  
...  
Keyword(s):  
Long Term Care ◽  
The Elderly ◽  
Population Ageing ◽  
Care Homes ◽  
Communication Tools ◽  
Term Care ◽  
Sharp Focus ◽  
Home Based ◽  
Institutionalized Patients

Telemedicine is now in vogue, being deployed through computer and communication tools in various health fields, such as diabetology, nephrology, dermatology, neurology, and cardiology. With population ageing, geriatrics is coming into sharp focus. Telemedicine practices differ for home-based or institutionalized patients in long-term care homes. We take a look at telemedicine projects in France concerning the elderly.

scholarly journals Consequences of isolation in elderly with and without dementia during the COVID-19 pandemic: a literature review

2021 ◽  
Author(s):  
Ana Carolina Pereira Garcia ◽  
Alice Campos Meneses ◽  
Ana Karolinne Cruz Cavalcante ◽  
Caroline Rodrigues de Morais ◽  
Gabriel Dias Henz ◽  
...  
Keyword(s):  
Literature Review ◽  
Elderly Patients ◽  
Social Isolation ◽  
Neuropsychiatric Symptoms ◽  
Social Contact ◽  
Disease Status ◽  
The Elderly ◽  
Social Consequences ◽  
Mood Stabilizers ◽  
Institutionalized Patients

Background: Elderly patients with and without dementia are especially vulnerable to COVID-19 infection due to their disease status, age and comorbidities, needing to face measures of social restrictions. However, it is known that social isolation is a risk factor for decline of cognitive functions. Objectives: Gather information about consequences of isolation in elderly patients with and without dementia during the COVID-19 pandemic. Methods: Narrative literature review through active search for publications on the topic on the PubMed platform, resulting in 17 articles for evaluation. Results: Apathy has shown to be the most common neuropsychiatric symptom of social isolation in the elderly, followed by irritability, agitation, aggression and depression. In institutionalized patients with dementia, there was an increased burden of neuropsychiatric symptoms by 60%, the main symptoms being anxiety, depression, sleep disorder, behavior aberrant motor and changes in appetite. In addition, limitation of outdoor activity and absence of direct social contact required an increased dosage of antipsychotic drugs and mood stabilizers. In a sample of individuals with mild cognitive decline, had decreased physical activity, reduced adherence to Mediterranean diet, and more than 35% had weight gain. Conclusions: Isolation has mental, physical and social consequences for the elderly with and without dementia, enhancing their fragility and vulnerability. Hence, it is necessary a follow up by the health system and family members, as well as the development of strategies to minimize such losses.

scholarly journals Cognitive performance of long-term institutionalized elderly patients with schizophrenia: A case control study

2011 ◽  
Vol 5 (2) ◽  
pp. 99-103 ◽  
Author(s):  
Alexandre Paim Diaz ◽  
Monica Zavaloni Scalco ◽  
Marcelo Libório Schwarzbold ◽  
Douglas Affonso Formolo ◽  
Alberto Stoppe Júnior
Keyword(s):  
Cognitive Impairment ◽  
Elderly Patients ◽  
Cognitive Performance ◽  
The Elderly ◽  
Psychiatric Diseases ◽  
Institutionalized Elderly ◽  
History Of ◽  
Language Abstraction ◽  
Institutionalized Patients

Abstract Cognitive impairment is inherent to the ageing process. Several studies suggest that patients with late-life schizophrenia have more marked cognitive impairment. Objective: The aim of this study was to compare the cognitive performance of elderly institutionalized patients with schizophrenia and institutionalized elderly control patients without neurological or psychiatric diseases, matched for age, educational level and institutionalization time. Methods: The Cambridge Examination for Mental Disorders of the Elderly (CAMCOG) was used to test 10 institutionalized elderly patients with schizophrenia. Results were compared with those of 10 institutionalized control patients with history of Hansen's disease. Results: Patients with schizophrenia showed a worse performance in terms of total CAMCOG score and on its subtests of orientation, language, abstraction, and memory (p≤0.05). Patients with schizophrenia also disclosed a non-significant trend toward lower scores on the MMSE and on calculus. Conclusion: Findings demonstrated that schizophrenia was associated to worse cognitive impairment in long-term institutionalized elderly patients compared with institutionalized patients without neurological or psychiatric diseases.

scholarly journals The role of vitamins in the diet of the elderly II. Water-soluble vitamins

2017 ◽  
Vol 10 (1) ◽  
pp. 146-166 ◽  
Author(s):  
J. Csapó ◽  
Cs. Albert ◽  
J. Prokisch
Keyword(s):  
The Elderly ◽  
Developed Countries ◽  
Vitamin Deficiency ◽  
The Body ◽  
Water Soluble ◽  
Dietary Vitamin ◽  
Human Organism ◽  
Biochemical Processes ◽  
Water Soluble Vitamin ◽  
Gastrointestinal Problems

AbstractFollowing a presentation of humans’ water-soluble vitamin requirements, the authors will discuss in detail the role these vitamins play in human organism and outline those major biochemical processes that are negatively affected in the body in case of vitamin deficiency. They point out that in the elderly population of developed countries cases of water-soluble vitamin deficiency are extremely rare and they are due to the lack of dietary vitamin, but mostly to the vitamin being released from its bindings, the difficulty of free vitamin absorption, gastrointestinal problems, medication, and often alcoholism. Among water-soluble vitamins, B12is the only one with a sufficient storage level in the body, capable of preventing deficiency symptoms for a long period of time in cases of vitamin-deficient nutrition. Each type of vitamin is dealt with separately in discussing the beneficial outcomes of their overconsumption regarding health, while the authors of the article also present cases with contradictory results. Daily requirements are set forth for every water-soluble vitamin and information is provided on the types of nutrients that help us to the water-soluble vitamins essential for the organism.

Paliperidone Palmitate in Psychogeriatric Patients and New Criteria Stopp-start

2016 ◽  
Vol 33 (S1) ◽  
pp. S471-S471
Author(s):  
I. Martinez Perez ◽  
F. García Sánchez ◽  
M.R. Raposo Hernandez ◽  
A. Gil Sánchez ◽  
A.L. Gonzalez Galdamez ◽  
...  
Keyword(s):  
Combination Therapy ◽  
The Elderly ◽  
Descriptive Study ◽  
Paliperidone Palmitate ◽  
Start Criteria ◽  
Competing Interest ◽  
Institutionalized Patients ◽  
Long Acting ◽  
New Criteria ◽  
Symptomatic Control

The treatment of psychosis in the elderly should ensure effectiveness and avoid side effects from combination therapy. Long acting antipsychotic as paliperidone palmitate facilitates this work. Furthermore, STOPP-START criteria, first published in 2008 (in Spanish in 2009), are being adopted as reference criteria throughout Europe. The Spanish version of the new 2014 edition is also recently published [1]. A descriptive study of a total of 53 institutionalized patients in psychogeriatric residence (> 60 to 97 years) with psychotic disorder diagnosis and treatment with various neuroleptics is done. In total, 26.4% of the sample admitted to treatment with three different antipsychotics, and 47.1% with combination of two antipsychotics. Only 26.4% worked with antipsychotic monotherapy. In these patients, treatment with paliperidone palmitate starts or sets the previous dose. A CGI scale is applied after six months of treatment. Antipsychotic monotherapy in 66.66% of patients on neuroleptic combination therapy was achieved, so that 75% of the sample currently maintains monotherapy with paliperidone palmitate. The paliperidone palmitate has shown effectiveness in the symptomatic control and reducing the risk of inapropiate prescribing in older patients with psicosis. The paliperidone palmitate allows antipsychotic monotherapy in the psychogeriatric patient with severe mental illness polymedicated as the STOPP-START criteria recommends.Reference not available.Disclosure of interestThe authors have not supplied their declaration of competing interest.

Major Depression in the Elderly: A Population Study in Helsinki

1996 ◽  
Vol 8 (3) ◽  
pp. 437-443 ◽  
Author(s):  
Jaakko Valvanne ◽  
Kati Juva ◽  
Timo Erkinjuntti ◽  
Reijo Tilvis
Keyword(s):  
Major Depression ◽  
Age Groups ◽  
The Elderly ◽  
Cerebrovascular Diseases ◽  
Poor Vision ◽  
Age Cohorts ◽  
Objective Health ◽  
Healthy Elderly ◽  
Institutionalized Patients ◽  
Healthy Elderly People

The aim of the study was to estimate the prevalence of major depression and to evaluate associated features in random age cohorts of 75, 80, and 85 years (N = 651). A clinical examination was made by experienced health center physicians, and major depression was diagnosed according to DSM-III criteria. The prevalence increased with age and was 1% to 4% in the age groups of 75 and 80 years, but 13% at the age of 85 years. No sex difference was found. The frequency of major depression was fourfold among institutionalized patients (16%) as compared to those living at home (4%). Major depression was strongly associated with objective health, intellectual functioning, and functional capacity. Depression was most common in subjects suffering from poor vision, urinary incontinence, or Parkinson's disease (odd ratios 4.2 to 4.9). Depression was also correlated with musculoskeletal disorders, coronary heart disease, and cerebrovascular diseases (odd ratios 2.5 to 3.4). The survey suggests that major depression is quite rare in healthy elderly people but common in disabled institutionalized patients.

Sign in / Sign up

Export Citation Format

Share Document